Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04769466 · ClinicalTrials.gov registry record · NA

LifeBio Memory Digital Reminiscence Platform

A NA study of Dementia and Cognitive Impairment, sponsored by Benjamin Rose Institute on Aging.

Completed
Registry status
NA
Development phase
234
Enrollment target
1
Study location

NCT04769466 is a NA study of Dementia and Cognitive Impairment that has completed, run by Benjamin Rose Institute on Aging. The registered enrollment target is 234 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04769466, a NA study of Dementia and Cognitive Impairment, has completed, sponsored by Benjamin Rose Institute on Aging.

COMPLETED
Registry status
NA
Development phase
234 participants
Enrollment target
1
Study location

Study Summary

Non-pharmacological interventions and person-centered care strategies are important elements of care for people with Alzheimer's disease and related dementias. Life story work, which uses written and oral life histories to elicit conversation and memories, is an effective intervention for individuals with dementia; however, because of the time-consuming nature of generating useful life story materials, has not been widely implemented in nursing homes and other care environments. LifeBio Inc. will develop an easy-to-use reminiscence therapy platform - LifeBio MemoryTM - with a novel machine-learning-based application that converts speech to text and generates life stories to serve as an interactive tool to cultivate communication between people living with dementia and their family and caregivers.

Interventions

  • OTHER LifeBio Memory

Study Locations (1)

Ohio

  • Benjamin Rose Institute on Aging - Cleveland

Trial Details

FieldValue
Enrollment Target 234 participants
Start Date 2022-03-22
Est. Completion 2024-04-30
Phase NA

Sponsor

Benjamin Rose Institute on Aging

2 total trials

What the Registry Record Tells You About NCT04769466

The ClinicalTrials.gov registry entry for NCT04769466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The listed sponsor is Benjamin Rose Institute on Aging, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which LifeBio Memory is the first listed.

NCT04769466 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04769466 about?

NCT04769466 is a clinical study titled "LifeBio Memory Digital Reminiscence Platform". Non-pharmacological interventions and person-centered care strategies are important elements of care for people with Alzheimer's disease and related dementias. Life story work, which uses written and oral life histories to elicit conversation and memories, is an effective intervention for individual...

What is the current status of trial NCT04769466?

This trial is currently completed. It is a NA study. The enrollment target is 234 participants. The study started on 2022-03-22. Estimated completion is 2024-04-30.

What conditions does trial NCT04769466 study?

This clinical trial studies the following conditions: Dementia, Cognitive Impairment.

What interventions are being tested in trial NCT04769466?

The interventions under investigation include: LifeBio Memory (OTHER).

Who is sponsoring clinical trial NCT04769466?

This trial is sponsored by Benjamin Rose Institute on Aging, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04769466 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.